Purpose: Clinical practice with people with intellectual disability relies heavily upon caregiver report. Crucially, the carer's perspective may depend upon his or her relationship to the patient. We investigated similarities and differences within and between family and paid carers in their reports on the Glasgow Epilepsy Outcome Scale (GEOS), an instrument that quantifies concerns about epilepsy in this population [Epilepsia 42 (2001[Epilepsia 42 ( ) 1043. Methods: GEOS forms were available on 186 patients (108 males; mean age 39 years) across 384 primary respondents (141 staff, 83 family, 160 clinicians) and independently completed secondary respondents (67 staff, 36 family). Data were analysed to consider levels of concern as rated bv staff carers, family members and clinicians, and also to consider inter-rater agreement on the concerns raised. Results: There were significant differences in the magnitude of concern on each sub-scale [concerns about seizures, treatment, caring and social impact; range of F(2, 171) = 9.5-64.7; all P < 0.0001]. Post hoc testing revealed that family members scored all sub-scales more highly than staff carers or clinicians, and that staff carers scored more highly than clinicians on all but one sub-scale. Inter-rater agreement between family members was considerably higher (range of r = 0.69-0.91) than between staff carers (r = 0.30-0.47) across the GEOS sub-scales. Association between staff and family ratings was also modest (r ≤ 0.39). Conclusions: It is preferable for the same staff member to complete each administration of the GEOS because of inter-staff variability in reporting of concerns. Families provide a consistent, but more extreme, picture and clinicians generally underestimate the concerns of direct caregivers. However, content of concerns varies relatively little across respondents.
INTRODUCTION
Many people with intellectual disability (mental retardation) have epilepsy. Prevalence rates vary, depending upon the source of the sample (e.g. community/ health facility), and the severity of neurological impairment, but around 25% appears to be a reasonable and conservative figure [2] [3] [4] . Thus, people with intellectual disability are 20-30 times more likely to have epilepsy than the general population 5, 6 . It follows that understanding the needs of this group is particularly important within any major epilepsy service.
Working clinically with people with intellectual disability, however, can be particularly challenging. Seizures may present in atypical ways, response to antiepileptic drugs (AEDs) may be less than optimal, and less good than in the wider epilepsy population, there are often co-morbid health, mental health or sensory difficulties, and effective communication usually has to be through a caregiver [7] [8] [9] [10] . Although there is increasing recognition of such factors in the literature [10] [11] [12] , in epilepsy service documents 13, 14 , and in disability-specific guidelines 8 , validated instruments are required to provide a metric of severity of problem and treatment-related change 12, 16 . This is not only a matter of having accurate data on frequency and type of seizures, but also a means of appraising epilepsy-related concerns, and appraising the intrusiveness of both the seizures themselves and the concerns about them, upon day to day life 15 .
In recent years we have been following a programme of research committed to the development of such measures (the Glasgow Epilepsy Outcome Scales (GEOSs) 1, 17, 18 ). Our approach has been to start with qualitative methodology, to identify the key issues for those involved with the person with epilepsy, and to progress through quantitative, scale development methods, to derive measures which have robust psychometric properties. We believe this approach is appropriate because the clinical assessment of people with intellectual disability and epilepsy must be able to take into account the background, experience and care perspective of the person expressing the patient's need at the outpatient appointment. After all, does a parent observe seizure events, and attach significance to them in the same way as a member of residential or day care or respite staff? Do different people's perspectives on the effects or side-effects of AEDs, or on improvement or deterioration in quality of life necessarily concur? Does the patient experience the same concerns about having epilepsy as members of his/her family? And what do clinicians by comparison feel are the major concerns?
Those working in this field recognise the importance of a reliable witness and informant, and would readily agree with the recommendation that the same carer should accompany the person with epilepsy and intellectual disability to each clinic appointment 8 . However, there are few if any data on this, and this principle may need to be reinforced by evidence in order to influence care practice. Besides, the differing perspectives that people may have require exploration because many people with intellectual disability have multiple carers, who come from different backgrounds and who form different types of attachment. Perhaps we should not expect unanimity of opinion or concern, but rather be equipped accurately to appraise a range of expressed needs.
METHODS
Our aim in this study was to investigate possible differences between the proxy reports of those directly involved in the care and management of people with epilepsy and intellectual disability. More specifically, we wanted to compare family carer reports with staff carer reports, to consider the association between reports provided by different family members and different members of care staff, and to compare clinician reports with both family and staff reports. Development work on the GEOS 1 provided the opportunity to study these important clinical matters.
Sample
A database of potential subjects was compiled comprising information on 685 people with epilepsy and intellectual disability in Glasgow and Edinburgh. Inclusion criteria were: (a) adults in the age range 18-60 years, (b) with at least mild intellectual disability according to World Health Organisation definitions (including previous attendance at 'special school'), (c) epilepsy confirmed by clinical history and diagnosis, (d) having a minimum of one seizure per month on average and (e) a carer (family and/or staff) who had participated in care decisions for at least the preceding 3 months. Exclusion criteria were deteriorating health, particularly neurological disorder, and/or established non-epileptic seizure disorder as the principal clinical problem. The database was used to select 250 using random number sequences generated by SPSS. Of these, seven carers refused participation and attempts to make contact with 54 were unsuccessful. Therefore, agreement to participate was reached for 189, however, three were excluded due to age (n = 2) and non-epileptic seizures (n = 1).
Measures
Our primary measure was the 90-item version of the Glasgow Epilepsy Outcome Scale (GEOS-90), an instrument specifically validated to assess carer concerns about epilepsy in people with intellectual disability 1 . The GEOS-90 yields four sub-scale scores; 'concerns about seizures' (30 items), 'concerns about treatment' (26 items), 'concerns about caring' (14 items) and 'concerns about social impact' (20 items). Respondents are asked to focus upon the epilepsy-related needs of the person they care for, over the preceding 3 months, and to rate each item using a 5-point Likert scale comprising-0 'never a concern/not applicable', 1 'only occasionally a concern', 2 'fairly often a concern', 3 'often a concern' and 4 'very often a concern'. The GEOS-90 and its sub-scales have strong internal consistency (α ≥ 0.94) and reasonable discriminant validity 1 . GEOS-90 forms were sent and returned by conventional mail. We also calculated GEOS-35 scores (the 35-item short-form version of the scale 1 ), and made similar comparisons using these.
A range of other measures was completed as part of a structured interview and history taken from carers. The Vineland Adaptive Behaviour Scales (V-ABS) 19 provided an estimate of patient functioning. Carer coping was assessed using the Caregiver Strain Index (CSI) 20 and the Hospital Anxiety and Depression Scale (HADS) 21 . We adapted the CSI, originally developed for use with carers of people after stroke, and found that it had acceptable internal consistency (α = 0.80) 22 . Carer knowledge of epilepsy was measured by Epilepsy Knowledge Profile (EKP) 23 .
RESULTS

Descriptive information
From the 186 retained participants (74%), 132 family carers and 173 staff carers were identified to complete the GEOS-90, which was returned completed by 83 (63%) and 141 (82%) carers, respectively. A second family member was identified for 36 patients, and a second paid carer for 67 patients. These carers also completed and returned the GEOS-90, independently of the principal carer. Clinicians involved in epilepsy management (mainly medical practitioners, but also some epilepsy nurse specialists and neuropsychologists) were identified for 172 of the 186 individuals, and, of these, 160 returned completed GEOS-90 forms (93%).
Care information
Nearly half of the 186 patients lived at home with relatives (n = 76, 41%) and a similar number lived in the community with staff carers (n = 84, 45%). The remaining 26 (14%) lived in an institutional setting. One hundred and eighteen (63%) lived in the Glasgow area, and 68 (37%) in the Edinburgh area, consistent with population estimates of people with intellectual disability in these districts. As anticipated, there were more males (n = 108, 58%) than females (n = 78, 42%). Mean age was 39 years in staffed care, significantly older than the mean of 31 years in clients who lived at home with family (mean diff. 7.69 years, CI 95% 4.45-10.9). Level of mental retardation was assessed from clinical sources. Three-quarters (n = 139, 75%) had at least moderate mental retardation, of whom 27 (15%) were profoundly retarded. Functional assessment on the V-ABS skills revealed that all had a deficit in adaptive daily living skills with 14 (8%) exhibiting borderline, 20 (11%) mild, 8 (4%) moderate, 15 (8%) severe and 128 (69%) profound deficit. No significant difference was found between those living at home and those 'in care'. One-quarter (n = 47, 25%) of the sample was non-ambulant, 27 (15%) had hearing impairment, 62 (33%) visual impairment and 55 (30%) had no speech.
The mean age of family carers was 57 years compared to 37 years in staff carers (mean diff. 19.4 years, CI 95% 16.0-22.8). Correspondingly, family carers had also known and cared for the person with epilepsy for significantly longer, a mean of 28.7 years compared to 5.8 years in staff carers. All carers, however, had cared for the individual for at least 3 months. Epilepsy knowledge did not differ significantly between staff and family carers. On the EKP medical sub-scale the overall mean score was 27 (79% correct) and on the social sub-scale it was 15.8 (71% correct). These scores are consistent with those reported in a recent study 17 . Levels of caregiver strain were assessed only in family carers because staff carer scores could not be linked to a specific person. Strain was found to be above average, with 43 carers (53%) scoring above the norm for 'higher than average stress' on the CSI. Using the recognised cut-off score of 11 on the HADS, 24 family carers (34%) reached 'caseness' on anxiety and 8 carers (11%) had significant depressive symptoms.
Clinical information
Epilepsy was most often managed by an epilepsy specialist/consultant neurologist (68%) and/or the client's general medical practitioner (49%). In many cases (n = 78, 42%) both the neurologist and GP were involved. In 14 cases (1%), epilepsy was not currently managed by any clinician. Polypharmacy was common: 62 patients (33%) were prescribed two AEDs, 58 (31%) three AEDs and 16 (9%) four or more AEDs. Fifty patients were on AED monotherapy (27%). Mean age at onset of epilepsy was 4.5 years, ranging from birth to 38 years. Seizure frequency varied enormously, ranging to over 2000 seizures per year. Forty clients (22%) had seizures at least daily, 63 (35%) had seizures at least weekly, 56 (31%) had at least one seizure per month and 22 (12%) less frequently (n = 181, five missing cases). Detailed descriptions of seizure presentations were obtained from the principal carer, including seizure patterns, nature of onset, duration, movements, incontinence, loss of consciousness/responsiveness, injuries and post-ictal behaviours. These descriptions were rated blind by an experienced epileptologist to obtain an assessment of likely seizure types (available n = 182). The majority of patients had more than one seizure type (52%). Most common were tonic-clonic (61%) and complex partial seizures (44%) with myoclonic and absence seizures each at 10%. Forty-four patients (24%) had some seizures coded as unclassifiable on the basis of available descriptions. Comparison of mean scores (SD) on the GEOSs as rated by clinicians (n = 160), staff carers (n = 141) and family members (n = 83). 
Between-group comparisons on the GEOS
Comparative data on the GEOS-90 and GEOS-35 total scale and sub-scale scores are presented in Table 1 .
As can be seen, family carers consistently expressed the greatest levels of concern about seizures, their treatment, about caring for the person with epilepsy and about its social impact. Their scores were typically 0.5-1.0 SD higher than staff carer scores, and 1.0-1.5 SD higher than clinician scores. Staff ratings were generally intermediate, and with the exception of concerns about social impact, were also significantly higher than clinician ratings on both the GEOS-90 and GEOS-35. This ordering of results across groups is illustrated in Fig. 1 , where GEOS-90 scores are presented as a percentage of the total possible sub-scale scores. Because each sub-scale comprises a different number of items, the conversion to percentages in Fig. 1 also permits comparison across sub-scales. It is clear that, despite highly significant inter-rater differences in terms of magnitude of concern, there appears to be a similar pattern across the sub-scale domains, particularly between the two carer groups. Family, staff carer and clinicians all rated concerns about seizures as marginally greater than the other sub-scales.
The above analyses make best use of our available data because they are on sizeable sub-groups (i.e. clinicians = 160, staff = 141, family = 83), thereby also serving the purpose of providing some normative GEOS data for these raters. However, we also analysed our data to look at score profiles on a within-subject basis, i.e. the clinician, staff carer and family carer scores for each individual. This is a much smaller dataset because not all subjects had both types of carer and also a clinician from whom ratings were available. We examined full data (three sets of GEOS scores) on 58 patients and found that for all sub-scales and total scores, for both the GEOS-90 and GEOS-35, one-way ANOVAs remained highly significant [range of F(2, 171) = 11.8-27.5; all P < 0.0001]. Post hoc testing (Bonferroni; P < 0.05) also confirmed that family carers scored significantly higher than either staff carers or clinicians on all sub-scales, and Because of epilepsy the person has less independence (Soc) 10 The person has one seizure after another (Sz)
Carers worry about the person having a seizure when out (Care)
Because of epilepsy carers lose their own independence (Care)
Items are from GEOS sub-scales as indicated (Sz = concerns about seizure; Tx = concerns about treatment; Care = concerns about caring; Soc = concerns about social impact).
that staff scored significantly higher than clinicians on concerns about seizures, treatment, and social impact on the GEOS-90, and on concerns about seizures on the GEOS-35. Total scores on both the GEOS-90 and GEOS-35 demonstrated significantly higher ratings for family over both staff and clinicians, and for staff carers over clinicians. Thus, our secondary analysis broadly confirmed the larger sample of data presented in Table 1 and Fig. 1 . Table 2 presents a rank order of the top 10 items in terms of mean score, for each of the sub-groups. This illustrates, similarly to Fig. 1 , that there was considerable communality of concern amongst family, staff carers and clinicians. For each of the three rater groups the same seven items were independently included; For staff comparisons n = 67 pairs of scores; for family n = 36 pairs of scores and for staff × family n = 40 pairs. a Intra-class correlation coefficient. b Product-moment correlation coefficient. * P < 0.01; ** P < 0.001; *** P < 0.0001. and the only item not reaching the top 10 for more than one group was ranked tenth. ('Because of epilepsy carers lose their own independence'-family carers listing.) Furthermore, each group included seven items reflecting concerns about seizures or their treatment, and three reflecting psychosocial concerns. Clinicians and family members had the same two items in the first two ranks. The overwhelming conclusion from this analysis is that it is primarily the magnitude of expressed concern that varies between these respondent groups rather than the nature or content of the scales per se.
Highest rated concerns on the GEOS-35 across groups
Inter-rater agreement on the GEOS
Intra-class and product-moment correlation coefficients were calculated for within-group and betweengroup measures of association, respectively (Table 3) . Inter-rater agreement between pairs of family members was high both for the GEOS-90 (range of r = 0.69-0.88) and GEOS-35 (r = 0.67-0.91). Agreement on three of the sub-scales of the GEOS-90 explained around two thirds of variance (r ≥ 0.83) and was at a similar level for the same three GEOS-35 sub-scales. Scores on the fourth sub-scale in each case, concerns about social impact, correlated 0.69 and 0.67, respectively (around 45% shared variance). Agreement between staff carers was more modest (r = 0.32-0.47 for GEOS-90, r = 0.31-0.42 for GEOS-35), typically representing around 15% of shared variance, although here social impact demonstrated inter-correlation at the higher end of the range. Association between staff and family ratings was also modest (r ≤ 0.29 for GEOS-90, r ≤ 0.39 for GEOS-35).
DISCUSSION
This study provides preliminary norms for the 90-and 35-item versions of the GEOS 1 on a modest sample (n = 186). These patients were drawn at random from a large clinical database of 685 people with epilepsy and intellectual disability, adding to the potential generalisability of the data. Nevertheless, we would encourage caution in interpreting our data for normative purposes until further cohorts are available from other geographical locations. Our primary aim, however, was not to establish norms, but to compare profiles of epilepsy-related Table 4 : Recommendations concerning the use of the GEOS scales in clinical practice with adults with epilepsy and intellectual disability.
1
The GEOS should be completed by a carer who is familiar with the person with epilepsy and intellectual disability; in particular being familiar with how epilepsy presents, its impact and its management 2 Ideally, the carer should have had direct involvement with the person for years. This will be so for family carers. In the case of care staff, lengthy direct involvement is also preferable, with 3 months at 'keyworker' level as the recommended minimum 3
Where both family members and staff carers are directly involved with the person's care it is preferable to have separate GEOS assessments from each source, each completed by the most appropriate person 4
When repeat assessment is planned (e.g. to appraise change in concerns about epilepsy over time), the same person(s) should be asked to complete the re-assessment 5
If it is not possible for the same family carer to do so, another family member may substitute providing she/he has also been directly involved (consistent with points 1 and 2 discussed earlier). This is because, in most cases, family members have similar concerns about epilepsy 6
If the same staff carer is unable to complete re-assessment, appraisal should be made of the extent to which the individual's epilepsy needs have been discussed within the care setting. The aim is to establish whether or not a shared understanding of the person's epilepsy and its impact is part of the person's overall plan of care. This is because it cannot otherwise be assumed that staff will have a similar perspective on concerns about epilepsy 7
If these conditions are satisfied, another staff member may substitute providing she/he has also been directly involved at 'keyworker' level (consistent with points 1 and 2 discussed earlier). If not, assessment by another member of staff may be best understood as representing a further baseline 8
Clinicians may also complete the scale, with the GEOS-35 being the most practicable. This may help the clinician toward greater appreciation of the potential impact of epilepsy 9 GEOS sub-scale profiles obtained from family, carer, or clinician informants may be compared with preliminary norms (Table 1) ; and profiles across more than one informant type may be compared with Fig. 1 which illustrates the differences in emphasis which may be expected 10
Information from the GEOS is intended as complementary to other means of appraising epilepsy-related needs. This appraisal should always take individual circumstances into account concerns, from the perspectives of a family member, a paid member of care staff and a clinician. Our findings of significant differences between these perspectives may be largely unsurprising to the experienced practitioner, but this has not in fact been reported previously in a formal study. We suggest that this demonstration of variability, primarily in the magnitude of emphases, accurately reflects valid differences in the priorities of informants, all of whom are in some respect 'stakeholders' in the care process. There are important implications for use of the GOES with this population, and some of these are listed in Table 4 . Family members have long histories of care involvement, have strong emotional attachments and traditionally have taken on the advocating role on behalf of their relative. We do not find it surprising, therefore, that their ratings on the GEOS were consistently the highest in all domains amongst the groups we compared. Indeed, the degree of concern expressed about epilepsy, bearing in mind that average time since diagnosis of epilepsy was some 25-30 years, pointedly illustrates the persisting importance of epilepsy in the life of the family. Our results also demonstrate that family members share a common perception of the needs of the person with epilepsy and intellectual disability. In our sample most of these pairings were mother/father or mother/sibling, and we obtained correlation coefficients of r = 0.83 and r = 0.85 for the GEOS-90 and GEOS-35. This level of between-subject, inter-rater agreement is, in fact, similar to what we obtained for within-subject, test re-test purposes on the pilot version of our scale (r = 0.86) 17 . This consistency, therefore, suggests that clinicians can be reasonably sure that they will hear a similar version of events from different members of the same family. In other words, there is likely to be a shared family perspective on the needs of and concerns about the person with epilepsy and intellectual disability.
The majority of the care staff who participated in our study was residential staff, principally the 'keyworkers' of our patients. These were all individuals who had known the person with epilepsy for a minimum of 3 months, and on average for almost 6 years. Although these carers also reported substantial concerns about epilepsy, their ratings for concerns about seizures, treatment, caring and social impact were considerably but fairly consistently lower (by 0.5-1.0 SD) than those provided by family members. Nevertheless, staff carer ratings were higher than those provided by clinicians for three of the four sub-scales (excepting social impact). Thus, we consider the GEOS staff score profile as intermediate in magnitude between family and clinician score profiles (Fig. 1) . Again, it is consistent with clinical experience that paid carers do not report concern about seizures in quite the same way as family. They tend to have less anxiety about events, perhaps because of the different nature of their relationship to the patient, the differing care history, and their primarily practical rather than emotional involvement.
These results should not be taken to mean that paid carers are in some respect less caring, or that families are more caring. This would be a naïve and inappropriate interpretation of our data. Rather, we would argue that it is inevitable that staff carers and family have a different perspective; because they approach the care situation from a different angle. We believe that both perspectives are valid, but that they are not wholly interchangeable (Table 4) . The correlation between family and staff carers was found to be significant but low (r = 0.20-0.39, depending upon sub-scale). Similarly, there appears to be less of a shared perspective amongst staff care groups because inter-rater correlation coefficients here ranged from r = 0.30 to 0.47. This latter finding reinforces the importance of the same member of staff accompanying the patient to clinic appointments 8 , and of the same person whenever possible completing the GEOS (Table 4) . Irrespective of this, however, we would suggest that such a level of agreement is unacceptably low. We recommend, therefore, that epilepsy needs should be made more central to the overall care management plan for the person with epilepsy and intellectual disability ( Table 4) , and that organisations providing care should ensure that staff involved develop a common understanding based upon shared concerns and priorities.
Perhaps it should be part of the 'keyworker' role to oversee the shared epilepsy care plan within the care setting. It should be noted that our study does not permit comparison across different care settings (e.g. residential, daycare, respite) and this might provide the focus for a further study.
Our data should not be taken to suggest a lack of concern amongst clinicians. Undeniably, practitioners completing the GEOS scored uniformly lower than family or staff carers, but their 'clinical' perspective may inevitably fail to capture the implications, intrusiveness and 'meaning' of epilepsy to those more intimately involved. Nevertheless, there was marked similarity in the principal concerns raised by our respondents, regardless of their type of involvement ( Table 2 ). The clinicians had three psychosocial items in their top 10 rank order, as did the family members and staff carers. Indeed, the highest ranking (at number 3) of a psychosocial item was found in the clinician data, suggesting at least that clinicians are aware of carer anxieties. Furthermore, clinicians and family members had the same items in ranks 1, 2 and 4. We are not particularly recommending the GEOS as a clinician-completed instrument in routine practice. For research purposes this additional comparison was of interest to us, and it may be in future studies. Nevertheless, some clinicians may find it practicable to complete the short-form version (GEOS-35), and it would be valuable to have more data for normative comparison of clinician scores.
We hope that the suggestions concerning use of the GEOS (Table 4) are justifiable on the basis of our results, and that they are also helpful to practitioners. We recognise that the client perspective is missing from this study, but we have been involved in a parallel study directly with people with intellectual disability, and this forms the basis of a separate report 18 . Much work is still required in the field of epilepsy and intellectual disability and we especially hope that our studies may prompt investigations of the GEOS in other geographical locations. There may also be benefits of applying our 'care perspective' methodology to other sub-populations of people with epilepsy. For example, we might reasonably expect different, but equally valid views, from parents, teachers and children in relation to epilepsy in childhood or teenage years; or from family carers, paid carers and older people with epilepsy.
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